首页> International journal of radiation oncology, biology, physics> Patterns of Relapse Following Radiation Therapy of Intermediate-Risk Prostate Cancer in the PROFIT Randomized Trial.

Patterns of Relapse Following Radiation Therapy of Intermediate-Risk Prostate Cancer in the PROFIT Randomized Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Martin,Langé

第一单位： Department of Radiation Oncology. Electronic address: martin.lange@ico.unicancer.fr.

作者： Martin,Langé ^[1] ; Loïc,Campion ^[2] ; Luc,Ollivier ^[3] ; Marion,Renouf ^[3] ; Nicolas,Magné ^[4] ; Igor,Latorzeff ^[5] ; Pascal,Pommier ^[6] ; Etienne,Martin ^[7] ; Amaury,Paumier ^[8] ; Guillaume,Bera ^[9] ; Charles,Catton ^[10] ; Jarad,Martin ^[11] ; Stephane,Supiot ^[12]

作者单位： Department of Radiation Oncology. Electronic address: martin.lange@ico.unicancer.fr. ^[1] Biostatistics, Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), UMR 1232 Inserm-6299 CNRS, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France. Electronic address: loic.campion@ico.unicancer.fr. ^[2] Department of Radiation Oncology. ^[3] Department of Radiation Oncology, Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez, France. ^[4] Department of Radiation Oncology, Oncorad Clinique Pasteur, Toulouse, France. ^[5] Department of Radiation Oncology, Centre Léon Bérard, Lyon, France. ^[6] Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon, France. ^[7] Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. ^[8] Department of Radiation Oncology, Hôpital du Scorff, Lorient, France. ^[9] Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada. ^[10] School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, New South Wales, Australia; Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, New South Wales, Australia. ^[11] Department of Radiation Oncology; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), UMR 1232 Inserm-6299 CNRS, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France; Nantes Université, Inserm 1307, CNRS 6075, Université d'Angers, CRCI2NA, Nantes, France. ^[12]